85 related articles for article (PubMed ID: 2854693)
1. Clinical evaluation of hemostatic molecular markers.
Kazama M
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1387-94. PubMed ID: 2854693
[No Abstract] [Full Text] [Related]
2. [A clinical study on hemostatic fluctuation during and after cardiopulmonary bypass using hemostatic molecular markers].
Nakajima H
Nihon Kyobu Geka Gakkai Zasshi; 1992 Nov; 40(11):1987-97. PubMed ID: 1336789
[TBL] [Abstract][Full Text] [Related]
3. Laboratory application of radioimmunoassay in the quantitation of molecular markers of hemostatic activation.
Walenga JM; Fareed J; Hoppensteadt D
Semin Thromb Hemost; 1984 Oct; 10(4):294-305. PubMed ID: 6240117
[No Abstract] [Full Text] [Related]
4. Impact of automation on the quantitation of low molecular weight markers of hemostatic defects.
Fareed J; Walenga JM; Bick RL; Bermes EJ; Messmore HL
Semin Thromb Hemost; 1983 Oct; 9(4):355-79. PubMed ID: 6229030
[TBL] [Abstract][Full Text] [Related]
5. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
[TBL] [Abstract][Full Text] [Related]
6. Plasmatic markers of haemostatic system activation in patients with solid neoplasms.
Sagripanti A; Carpi A; Ferdeghini M; Baicchi U; Grassi B
J Nucl Med Allied Sci; 1990; 34(4):321-32. PubMed ID: 2151044
[No Abstract] [Full Text] [Related]
7. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
van Hulsteijn H; Fibbe W; Bertina R; Briët E
Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
[TBL] [Abstract][Full Text] [Related]
8. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
Roy MS; Podgor MJ; Rick ME
Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
[TBL] [Abstract][Full Text] [Related]
9. The role of natural coagulation inhibitors in hemostasis.
Brandt JT
Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
[TBL] [Abstract][Full Text] [Related]
10. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
Sie P
Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
[No Abstract] [Full Text] [Related]
11. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
12. [Role of fibrinopeptide A and D-dimer in diagnostics of hemostasis disorders].
Riabov GA; Pasechnik IN; Azizov IuM
Anesteziol Reanimatol; 2003; (1):69-74. PubMed ID: 12696462
[No Abstract] [Full Text] [Related]
13. The overall hemostasis potential: a laboratory tool for the investigation of global hemostasis.
Antovic A
Semin Thromb Hemost; 2010 Oct; 36(7):772-9. PubMed ID: 20978998
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.
Kyrle PA; Westwick J; Scully MF; Kakkar VV; Lewis GP
Thromb Haemost; 1987 Feb; 57(1):62-6. PubMed ID: 2954260
[TBL] [Abstract][Full Text] [Related]
15. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
Arshinov AV; Lapin VA; Raĭt IuA
Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
[TBL] [Abstract][Full Text] [Related]
16. The regulation of hemostasis: the protein C system.
Clouse LH; Comp PC
N Engl J Med; 1986 May; 314(20):1298-304. PubMed ID: 3010107
[No Abstract] [Full Text] [Related]
17. Impaired fibrinolytic response to increased thrombin activation in type 1 diabetes mellitus: effects of the glycosaminoglycan sulodexide.
Ceriello A; Quatraro A; Marchi E; Barbanti M; Giugliano D
Diabete Metab; 1993; 19(2):225-9. PubMed ID: 8339853
[TBL] [Abstract][Full Text] [Related]
18. Hemostasis during normal pregnancy and puerperium.
Hellgren M
Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives and the hemostatic system.
Farag AM; Bottoms SF; Mammen EF; Hosni MA; Ali AA; Moghissi KS
Obstet Gynecol; 1988 Apr; 71(4):584-8. PubMed ID: 3353050
[TBL] [Abstract][Full Text] [Related]
20. [Electrocoagulography using integral indices in assessing hemostatic disorders in children].
Baranov AA
Anesteziol Reanimatol; 1988; (6):59-61. PubMed ID: 3245625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
